Experts debate use of toric, premium IOLs in eyes with abnormal corneas

SAN FRANCISCO — Two speakers here debated the efficacy of toric and premium IOLs in patients with abnormal corneal topography.Charles D. Reilly, MD, and Michael W. Belin, MD, spoke during Cornea Day preceding the American Society of Cataract and Refractive Surgery meeting.

Full Story →